Can Leuprolide be used in the management of benign prostatic hyperplasia (BPH), and how does it influence prostate size and urinary symptoms?
Gaurav ChauhanContributor
IVF Questions & Answers
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Can Leuprolide be used in the management of benign prostatic hyperplasia (BPH), and how does it influence prostate size and urinary symptoms?
Leuprolide, a GnRH agonist, can be used in BPH to reduce prostate size and alleviate urinary symptoms by decreasing testosterone levels.
Leuprolide, primarily for prostate cancer, may also manage BPH by curtailing testosterone, thus reducing prostate volume and improving urinary flow.
Leuprolide is primarily used for prostate cancer, not BPH. It can reduce prostate size and improve urinary symptoms by inhibiting testosterone production. However, it’s not a standard treatment for BPH.